Compare TIC & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TIC | HTFL |
|---|---|---|
| Founded | 1991 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | 2025 |
| Metric | TIC | HTFL |
|---|---|---|
| Price | $9.51 | $27.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $14.63 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 2.3M | 1.5M |
| Earning Date | 03-27-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,284,070,000.00 | $161,881,000.00 |
| Revenue This Year | $41.97 | $40.42 |
| Revenue Next Year | $42.94 | $22.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.15 | ★ 85.70 |
| 52 Week Low | $8.76 | $25.38 |
| 52 Week High | $14.94 | $41.22 |
| Indicator | TIC | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 28.12 | 30.33 |
| Support Level | $8.90 | $27.45 |
| Resistance Level | $10.21 | $30.19 |
| Average True Range (ATR) | 0.46 | 1.98 |
| MACD | -0.22 | -0.84 |
| Stochastic Oscillator | 3.10 | 1.35 |
TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.